Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 761

1.

When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain.

Arango C, Bernardo M, Bonet P, Cabrera A, Crespo-Facorro B, Cuesta MJ, González N, Parrabera S, Sanjuan J, Serrano A, Vieta E, Lennox BR, Melau M.

Rev Psiquiatr Salud Ment. 2017 Feb 8. pii: S1888-9891(17)30016-2. doi: 10.1016/j.rpsm.2017.01.001. [Epub ahead of print] English, Spanish.

2.

The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.

Mezquida G, Cabrera B, Bioque M, Amoretti S, Lobo A, González-Pinto A, Espliego A, Corripio I, Vieta E, Castro-Fornieles J, Bergé D, Escartí MJ, Ibañez Á, Penadés R, Sánchez-Torres AM, Bernardo M; PEPs Group..

Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30060-9. doi: 10.1016/j.schres.2017.01.047. [Epub ahead of print]

PMID:
28185786
3.

Clinical, Cognitive, and Neuroimaging Evidence of a Neurodevelopmental Continuum in Offspring of Probands With Schizophrenia and Bipolar Disorder.

Sugranyes G, de la Serna E, Borras R, Sanchez-Gistau V, Pariente JC, Romero S, Baeza I, Díaz-Caneja CM, Rodriguez-Toscano E, Moreno C, Bernardo M, Moreno D, Vieta E, Castro-Fornieles J.

Schizophr Bull. 2017 Feb 9. doi: 10.1093/schbul/sbx002. [Epub ahead of print] No abstract available.

PMID:
28180904
4.

Modelling gene-environment interaction in first episodes of psychosis.

Bernardo M, Bioque M, Cabrera B, Lobo A, González-Pinto A, Pina L, Corripio I, Sanjuán J, Mané A, Castro-Fornieles J, Vieta E, Arango C, Mezquida G, Gassó P, Parellada M, Saiz-Ruiz J, Cuesta MJ, Mas S; PEPs GROUP..

Schizophr Res. 2017 Feb 5. pii: S0920-9964(17)30068-3. doi: 10.1016/j.schres.2017.01.058. [Epub ahead of print]

PMID:
28179063
5.

In vitro study of the effect of an essential oil and a delmopinol mouth rinse on dental plaque bacteria.

LuIs HS, Luis LS, Bernardo M.

Indian J Dent Res. 2016 Nov-Dec;27(6):648-651. doi: 10.4103/0970-9290.199602.

6.

Central Corneal Thickness After Cross-linking Using High-Definition Optical Coherence Tomography, Ultrasound, and Dual Scheimpflug Tomography: A Comparative Study Over One Year.

De Bernardo M, Rosa N.

Am J Ophthalmol. 2017 Jan 31. pii: S0002-9394(17)30013-2. doi: 10.1016/j.ajo.2017.01.007. [Epub ahead of print] No abstract available.

PMID:
28159112
7.

Comparison of specular microscopy and ultrasound pachymetry before and after cataract surgery.

De Bernardo M, Rosa N.

Graefes Arch Clin Exp Ophthalmol. 2017 Feb 3. doi: 10.1007/s00417-017-3604-2. [Epub ahead of print] No abstract available.

PMID:
28154931
8.

Cannabis use, COMT, BDNF and age at first-episode psychosis.

Mané A, Bergé D, Penzol MJ, Parellada M, Bioque M, Lobo A, González-Pinto A, Corripio I, Cabrera B, Sánchez-Torres AM, Saiz-Ruiz J, Bernardo M, Group P.

Psychiatry Res. 2017 Jan 19;250:38-43. doi: 10.1016/j.psychres.2017.01.045. [Epub ahead of print]

PMID:
28142064
9.

Metabolic syndrome or glucose challenge in first episode of psychosis?

Garcia-Rizo C, Fernandez-Egea E, Oliveira C, Meseguer A, Cabrera B, Mezquida G, Bioque M, Penades R, Parellada E, Bernardo M, Kirkpatrick B.

Eur Psychiatry. 2016 Dec 30;41:42-46. doi: 10.1016/j.eurpsy.2016.10.001. [Epub ahead of print]

PMID:
28049080
10.

The secretion and biological function of tumor suppressor maspin as an exosome cargo protein.

Dean I, Dzinic SH, Bernardo MM, Zou Y, Kimler V, Li X, Kaplun A, Granneman J, Mao G, Sheng S.

Oncotarget. 2017 Jan 31;8(5):8043-8056. doi: 10.18632/oncotarget.13302.

11.

In-Silico Analysis and Implementation of a Multicellular Feedback Control Strategy in a Synthetic Bacterial Consortium.

Fiore G, Matyjaszkiewicz A, Annunziata F, Grierson C, Savery NJ, Marucci L, di Bernardo M.

ACS Synth Biol. 2016 Dec 20. doi: 10.1021/acssynbio.6b00220. [Epub ahead of print]

PMID:
27997140
12.

Quality of Life According to Urgency Status in De Novo Heart Transplant Recipients.

Díaz-Molina B, Lambert JL, Vílchez FG, Cadenas F, Bernardo MJ, Velasco E, Martín M, Morís C.

Transplant Proc. 2016 Nov;48(9):3024-3026. doi: 10.1016/j.transproceed.2016.09.011.

PMID:
27932137
13.

An Essential Role of Maspin in Embryogenesis and Tumor Suppression.

Dzinic SH, Bernardo MM, Li X, Fernandez-Valdivia R, Ho YS, Mi QS, Bandyopadhyay S, Lonardo F, Vranic S, Oliveira DS, Bonfil RD, Dyson G, Chen K, Omerovic A, Sheng X, Han X, Wu D, Bi X, Cabaravdic D, Jakupovic U, Wahba M, Pang A, Harajli D, Sakr WA, Sheng S.

Cancer Res. 2017 Feb 15;77(4):886-896. doi: 10.1158/0008-5472.CAN-16-2219.

PMID:
27923833
14.

Synchronization and local convergence analysis of networks with dynamic diffusive coupling.

Burbano Lombana DA, di Bernardo M.

Chaos. 2016 Nov;26(11):116308.

PMID:
27907998
15.

Bone marrow-derived CD34- fraction: A rich source of mesenchymal stromal cells for clinical application.

Ingo DM, Redaelli D, Rossella V, Perini O, Santoleri L, Ciceri F, Aiuti A, Bernardo ME.

Cytotherapy. 2016 Dec;18(12):1560-1563. doi: 10.1016/j.jcyt.2016.08.011. No abstract available.

PMID:
27742233
16.

Antipsychotic Response Worsens With Postmenopausal Duration in Women With Schizophrenia.

González-Rodríguez A, Catalán R, Penadés R, Ruiz Cortés V, Torra M, Seeman MV, Bernardo M.

J Clin Psychopharmacol. 2016 Dec;36(6):580-587.

PMID:
27626286
17.

Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project.

Crespo-Facorro B, Bernardo M, Argimon JM, Arrojo M, Bravo-Ortiz MF, Cabrera-Cifuentes A, Carretero-Román J, Franco-Martín MA, García-Portilla P, Haro JM, Olivares JM, Penadés R, Del Pino-Montes J, Sanjuán J, Arango C.

Rev Psiquiatr Salud Ment. 2017 Jan - Mar;10(1):4-20. doi: 10.1016/j.rpsm.2016.09.001. English, Spanish.

18.

Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress.

Conforti A, Starc N, Biagini S, Tomao L, Pitisci A, Algeri M, Sirleto P, Novelli A, Grisendi G, Candini O, Carella C, Dominici M, Locatelli F, Bernardo ME.

Oncotarget. 2016 Nov 22;7(47):77416-77429. doi: 10.18632/oncotarget.12678.

19.

Is cerebrovascular disease a silent condition in patients with chronic schizophrenia-related disorders?

Berrocal-Izquierdo N, Bioque M, Bernardo M.

Int Clin Psychopharmacol. 2017 Mar;32(2):80-86. doi: 10.1097/YIC.0000000000000153.

PMID:
27755155
20.

Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.

Mezquida G, Penadés R, Cabrera B, Savulich G, Lobo A, González-Pinto A, Penzol MJ, Corripio I, Fernandez-Egea E, Gassó P, Cuesta MJ, Bernardo M; PEPs group..

Eur Psychiatry. 2016 Oct;38:61-69. doi: 10.1016/j.eurpsy.2016.04.011.

PMID:
27668551
Items per page

Supplemental Content

Loading ...
Support Center